Cephalon Agrees to Buy Gemin X Pharmaceuticals for up to US$525 M
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 4 (Table of Contents)
Published: 11 Apr-2011
DOI: 10.3833/pdr.v2011.i4.1456 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Cephalon has entered into an agreement to acquire privately held Gemin X Pharmaceuticals for US$225 M upfront and up to an additional US$300 M upon the achievement of certain regulatory and sales milestones...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS